Brief: Haemonetics Earns CE Mark For Vascade® Vascular Closure Product Portfolio
12/09/2022 11:45
Sept 12 (Reuters) - Haemonetics Corp HAE.N :
* HAEMONETICS EARNS CE MARK FOR VASCADE® VASCULAR CLOSURE
PRODUCT
PORTFOLIO
Source text for Eikon: ID:nPn9VkvBxa
Further company coverage: HAE.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Haemonetics
See all newsBrief: Haemonetics Announces FDA Approval Of Perqseal® Elite Vascular Closure System
Haemonetics says FDA clears vascular closure device
US STOCKS ON THE MOVE-Palantir, Haemonetics
U.S. STOCKS ON THE MOVE-Palantir, Haemonetics, Starbucks
Haemonetics surges as CSL plans to move all US plasma centers to its devices